Together, these findings suggest that targeting lipid scavenging could be a more effective therapeutic approach to target the increased lipid demand of proliferating cancer cells, though any such strategy would have to overcome the redundancy of alternate albumin-bound lipid sources. The gene discussed is ALB; the disease is cancer.